Nightstar Therapeutics

Nightstar Therapeutics plc (NASDAQ: NITE) is a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases including choroideremia, X-linked retinitis pigmentosa and Best vitelliform macular dystrophy.
Social Link - Linkedin: http://www. linkedin.com/company /nightstarx-limited
Employee Count: 3
Keywords: stargardt disease